blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3736272

EP3736272 - NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  10.06.2022
Database last updated on 18.10.2024
FormerRequest for examination was made
Status updated on  14.05.2021
FormerThe application has been published
Status updated on  09.10.2020
Most recent event   Tooltip14.08.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
The National Institute for Biotechnology in the Negev Ltd.
Ben-Gurion University
P.O. Box 653
8410501 Beer-Sheva / IL
[2020/46]
Inventor(s)01 / SHOSHAN-BARMATZ, Varda
9 Livne St.
84965 Omer / IL
02 / LEV GRUZMAN, Arie
25/14 Kubobi St.
9675737 Jerusalem / IL
 [2020/46]
Representative(s)Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
[2020/46]
Application number, filing date20175497.513.09.2016
[2020/46]
Priority number, dateUS201562217986P14.09.2015         Original published format: US 201562217986 P
[2020/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3736272
Date:11.11.2020
Language:EN
[2020/46]
Search report(s)(Supplementary) European search report - dispatched on:EP08.10.2020
ClassificationIPC:C07D471/10, A61K31/445, A61K31/4965, C07D241/54, A61P43/00, C07D211/66, C07D295/15, C07D241/04, C07D403/04, A61P9/00, A61P25/28, A61P25/16, A61P9/06, C07D401/04, C07D207/36, C07D207/416, C07D207/273, A61K31/454, A61K31/435
[2020/46]
CPC:
C07D295/15 (EP,IL,US); C07D211/66 (EP,CN,IL,US); A61K31/435 (EP,IL,US);
A61K31/445 (EP,IL,US); A61K31/454 (EP,IL,US); A61K31/4965 (EP,IL,US);
A61P25/00 (CN); A61P25/16 (EP,CN,IL,US); A61P25/28 (EP,CN,IL,US);
A61P9/00 (EP,CN,IL,US); A61P9/04 (CN); A61P9/06 (EP,CN,IL,US);
A61P9/10 (CN); C07D207/273 (EP,IL,US); C07D207/36 (EP,IL,US);
C07D207/416 (EP,IL,US); C07D401/04 (EP,IL,US); C07D471/10 (EP,IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/24]
Former [2020/46]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:NEUARTIGE PIPERAZIN- UND PIPERIDINDERIVATE, DEREN SYNTHESE UND VERWENDUNG DAVON ZUR HEMMUNG DER VDAC-OLIGOMERISIERUNG, APOPTOSE UND MITOCHONDRIENDYSFUNKTION[2020/46]
English:NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION[2020/46]
French:NOUVEAUX DÉRIVÉS DE PIPÉRAZINE ET PIPÉRIDINE, LEUR SYNTHÈSE ET UTILISATION ASSOCIÉE POUR INHIBER L'OLIGOMÉRISATION DE VDAC, L'APOPTOSE ET LE DYSFONCTIONNEMENT MITOCHONDRIAL[2020/46]
Examination procedure06.05.2021Amendment by applicant (claims and/or description)
06.05.2021Examination requested  [2021/24]
06.05.2021Date on which the examining division has become responsible
09.06.2022Despatch of a communication from the examining division (Time limit: M06)
07.12.2022Reply to a communication from the examining division
13.08.2024Despatch of a communication from the examining division (Time limit: M04)
Parent application(s)   TooltipEP16845836.2  / EP3350182
Fees paidRenewal fee
19.05.2020Renewal fee patent year 03
19.05.2020Renewal fee patent year 04
23.09.2020Renewal fee patent year 05
15.09.2021Renewal fee patent year 06
21.09.2022Renewal fee patent year 07
11.09.2023Renewal fee patent year 08
13.08.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]CN1944424  (CHINA UNIV OF PHARMACY [CN]);
 [A]CN1948298  (UNIV DONGNAN [CN]);
 [A]WO2008063984  (KING PHARMACEUTICALS RES & DEV [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.